The table below shows RHYTHM PHARMACEUTICALS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$60.11M
$51.30M
$48.50M
$32.70M
$33.25M
$29.08M
Cost of revenue
$7.16M
$5.50M
$5.54M
$3.65M
$3.83M
$2.95M
Gross profit
-
-
-
-
-
-
R&D
$41.73M
$46.03M
$42.31M
$36.97M
$37.93M
$30.19M
RYTM annual revenue (10-K history)
RHYTHM PHARMACEUTICALS, INC. reported annual revenue of $189.76M for fiscal year 2025. That is up 45.8% from $130.13M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
